Intelligence · Clinical Development
Pipeline search results
Programs matching “sirolimus” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 14 pipeline programs matching "sirolimus" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Sirolimus
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lupus Nephritis
1 trial -
Sirolimus
Ultragenyx UK Limited
Lymphangioleiomyomatosis
1 trial -
SIROLIMUS
Pari Pharma GmbH
Adult patients (men and women) (≥ 18 years of age) with cutaneous sarcoidosis involving the face
1 trial -
SIROLIMUS, SIROLIMUS
Lacuna Pharma Pty Ltd
Subjects diagnosed with port wine stains
1 trial -
Sirolimus
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Plastic Bronchitis
1 trial -
Sirolimus
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hemangioendothelioma
1 trial -
Sirolimus
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Kaposiform Hemangioendothelioma
1 trial -
Sirolimus
Ultragenyx UK Limited
Anemia, Aplastic
1 trial -
Sirolimus 0.5 mg
Ultragenyx UK Limited
Beta-Thalassemia
2 trials -
Temsirolimus
PUMA BIOTECHNOLOGY, INC.
Breast Cancer
1 trial -
sirolimus
Cardiff Oncology
Tuberous Sclerosis
1 trial -
SIMA SPK 01
The George Institute
End-stage kidney disease in Type 1 diabetes, SIROLIMUS VERSUS MYCOPHENOLATE MOFETIL IN SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANTATION TO EVALUATE THE RISK OF HERNIA
1 trial -
Sirolimus
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Antiphospholipid (aPL)-Positive
1 trial -
temsirolimus
Pfizer
Non-Hodgkin's Lymphoma
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.